1.
Enferm Infecc Microbiol Clin
; 26(2): 120-1, 2008 Feb.
Article
in Spanish
| MEDLINE
| ID: mdl-18341927
Subject(s)
Antiviral Agents/adverse effects , Diabetes Mellitus, Type 2/chemically induced , Hepatitis C, Chronic/drug therapy , Interferon-alpha/adverse effects , Polyethylene Glycols/adverse effects , Adult , Anti-HIV Agents/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Diabetes Mellitus, Type 2/epidemiology , Diabetic Ketoacidosis/chemically induced , Drug Therapy, Combination , HIV Infections/complications , HIV Infections/drug therapy , Hepatitis C, Chronic/complications , Humans , Incidence , Interferon alpha-2 , Interferon-alpha/administration & dosage , Interferon-alpha/therapeutic use , Male , Polyethylene Glycols/administration & dosage , Polyethylene Glycols/therapeutic use , Recombinant Proteins , Ribavirin/administration & dosage , Ribavirin/therapeutic use
2.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 26(2): 120-121, feb. 2008.
Article
in Es
| IBECS
| ID: ibc-64135
ABSTRACT
No disponible